NEW YORK, June 2, 2010 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ), the world's largest exchange company, announced that the trading of GenMark Diagnostics, Inc. commenced May 28 on The NASDAQ Stock Market. GenMark Diagnostics, Inc. is based in Pasadena, California and trades under the ticker symbol (Nasdaq:GNMK).
"Southern California's healthcare technology sector has always been a focus for us, and we are thrilled to welcome GenMark to The NASDAQ Stock Market," said Bruce Aust, Executive Vice President, Corporate Client Group, NASDAQ OMX. "We at NASDAQ consider ourselves innovators as a forward-thinking technology-focused exchange. Our partnership with GenMark, a ground-breaker in molecular diagnostics, aligns perfectly with this belief, and we look forward to a long relationship with one of the globe's most exciting tech visionaries."
NASDAQ has attracted more than 30 new listings YTD – a number that represents an approximate 50% increase over NASDAQ IPOs captured during Q1 2009. As of May 31, 2010, NASDAQ has raised roughly $2.5 Billion in proceeds. Notable NASDAQ IPOs for 2010 include IT companies QuinStreet (Nasdaq:QNST), which has raised over $150,000,000 in proceeds, Mitel Networks, Inc. (Nasdaq:MITL), and SS&C Technologies (Nasdaq:SSNC).
About GenMark Diagnostics, Inc.
GenMark Diagnostics is the planned Delaware parent company of Osmetech, plc, a corporation registered in England and Wales. GenMark is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor® detection technology. GenMark's XT-8 System enables multiplex detection of DNA and RNA targets. The company is currently in the process of commercializing three FDA-cleared diagnostic tests for use with its XT-8 System, a Cystic Fibrosis Genotyping Test, a Thrombofilia Risk Test and a Warfarin Sensitivity Test. GenMark is based in Pasadena, California.
About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein may contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to, factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
Neither The NASDAQ OMX Group, Inc., nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investors should undertake their own due diligence and carefully evaluate companies before investing.
NDAQG